Usos médicos y terapéuticos del cannabis y los cannabinoides. Desde su creación, el Programa de Política de Drogas de México Unido contra la Delincuencia ha buscado reformar las leyes y políticas de drogas de México y América Latina con el objetivo de que se basen en evidencia científca e integren las perspectivas de salud pública, derechos humanos, reducción del daño y desarrollo sostenible.
The ubiquitous cannabinoid receptors (CBRs) – probably the most abundant binding sites in the CNS - are known to be involved in a number of neuropsychiatric disturbances. CBRs are coded in human chromosomes 1 and 6 and activated by endocannabinoids, phytocannabinoids and marijuana use (medical/recreational use).
In the late 1960s, the dramatic increase in the casual use of marijuana raised questions about its potential adverse effects on health. In 1972, Harmon and Aliapoulios1 provided the first report of marijuana’s clinical impact on the endocrine system with the initial description of marijuana-associated gynecomastia.
A central tenet underlying the use of plant preparations is that herbs contain many bioactive compounds. Cannabis contains tetrahydrocannabinols (THC) a primary metabolite with reported psychotropic effects. - Maria Rosana Ramirez / ARGENTINA -
During the last few years, the endocannabinoid system has emerged as a highly relevant topic in the scientific community. Many different regulatory actions have been attributed to endocannabinoids, and their involvement in several pathophysiological conditions is under intense scrutiny.
A large body of evidence shows that cannabinoids, in addition to their well known palliative effects on some cancer-associated symptoms, can reduce tumour growth in animal models of cancer.
Hipotiroidismo: Some of the earliest reports of the effects of cannabis consumption on humans were related to endocrine system changes.